The global hydrocephalus market size is expected to grow from $3.12 billion in 2021 to $3.26 billion in 2022 at a compound annual growth rate (CAGR) of 4.2%. The global hydrocephalus market size is expected to grow to $3.84 billion in 2026 at a CAGR of 4.2%.
What is the Global Hydrocephalus Market?
The hydrocephalus market consists of sales of hydrocephalus devices (organizations, sole traders, and partnerships) that are used for the treatment of hydrocephalus. Hydrocephalus is a medical condition in which the cerebrospinal fluid (CSF) that commonly passes through the spaces of the brain and spinal column in normal circumstances starts accumulating in the cavities of brain structures, resulting in a variety of cognitive abnormalities. Head enlargement is an indication of hydrocephalus in infants. The various symptoms of hydrocephalus are headaches, blurred vision, cognitive impairments, loss of coordination, and incontinence.
Get a Sample of the global hydrocephalus market report
https://www.thebusinessresearchcompany.com/sample.aspx?id=6259&&type=smp
What drives the Global Hydrocephalus Market?
The increased prevalence of hydrocephalus is significantly contributing to the growth of the hydrocephalus market. Hydrocephalus is a medical condition in which the cerebrospinal fluid (CSF) starts accumulating in the cavities of brain structures, resulting in a variety of cognitive abnormalities. The increasing incidences of hydrocephalus are increasing the demand for hydrocephalus treatment devices to treat the patients. For instance, according to a 2021 report published in the National Center for Biotechnology Information, a part of the United States National Library of Medicine, a branch of the National Institutes of Health, the global prevalence of hydrocephalus is reported to be around 85 per 100,000 people, with a notable disparity between age groups 88 per 100,000 in children and 11 per 100,000 in adults. The prevalence is substantially higher in the senior population, around 175 per 100,000, and more than 400 per 100,000 for those over 80 years old. Therefore, increased prevalence of hydrocephalus is expected to propel the growth of the hydrocephalus market.
Get the full global hydrocephalus industry report here
https://www.thebusinessresearchcompany.com/report/hydrocephalus-global-market-report
Global Hydrocephalus Market Segments
The global hydrocephalus market is segmented:
By Type: Congenital Hydrocephalus, Acquired Hydrocephalus, Normal-Pressure Hydrocephalus, Ex-Vacuo Hydrocephalus
By Age Group: Pediatric, Adult
By Diagnostics: MRI, CT Scan, Head Ultrasound, Others
By End-User: Hospitals, Diagnostic Centers, Academic Institutions, Research Organizations
By Geography: The regions covered in the hydrocephalus market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Hydrocephalus Global Market Report 2022provides market size and growth forecasts for the global hydrocephalus market, global hydrocephalus market share, hydrocephalus market segments and geographies, hydrocephalus market competitive landscape including leading competitors’ revenues, profiles and market shares. The hydrocephalus market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Global Hydrocephalus Industry Playersinclude Christoph Miethke GmbH & Co. KG, Medtronic Plc, Sophysa, Tokibo Co. Ltd., Spiegelberg GmbH & Co. KG., B. Braun Melsungen AG, Alcyone Therapeutics Inc., Natus Medical Incorporated, HpBio Proteses Inc., Surgiwear Ltd., and Kaneka Medix Corporation. Based on industry trends and company analysis, the report explains a number of strategies for companies in the market.
